Your browser doesn't support javascript.
loading
Interatrial Shunting for Treating Acute and Chronic Left Heart Failure.
Guimaraes, Leonardo; Del Val, David; Bergeron, Sebastien; O'Connor, Kim; Bernier, Mathieu; Rodés-Cabau, Josep.
Afiliação
  • Guimaraes L; Department of Cardiology, Quebec Heart and Lung Institute, Laval University Quebec City, Quebec, Canada.
  • Del Val D; Department of Cardiology, Quebec Heart and Lung Institute, Laval University Quebec City, Quebec, Canada.
  • Bergeron S; Department of Cardiology, Quebec Heart and Lung Institute, Laval University Quebec City, Quebec, Canada.
  • O'Connor K; Department of Cardiology, Quebec Heart and Lung Institute, Laval University Quebec City, Quebec, Canada.
  • Bernier M; Department of Cardiology, Quebec Heart and Lung Institute, Laval University Quebec City, Quebec, Canada.
  • Rodés-Cabau J; Department of Cardiology, Quebec Heart and Lung Institute, Laval University Quebec City, Quebec, Canada.
Eur Cardiol ; 15: e18, 2020 Feb.
Article em En | MEDLINE | ID: mdl-32419849
ABSTRACT
The creation of an interatrial shunt has emerged as a new therapy to decompress the left atrium in patients with acute and chronic left heart failure (HF). Current data support the safety of this therapy, and promising preliminary efficacy results have been reported in patients who are refractory to optimal medical/device therapy. This article aims to provide an updated overview and clinical perspective on interatrial shunting for treating different HF conditions, and highlights the potential challenges and future directions of this therapy.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article